Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-09 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
S | Common Stock | D | 3689 | $31.18 - $31.18 | $115,023 |
| 2024-04-09 | Immunovant, Inc. | Butchko Julia G.
(Chief Development Officer) |
S | Common Stock | D | 1053 | $31.18 - $31.18 | $32,832 |
| 2024-04-02 | Immunovant, Inc. | Fromkin Andrew J.
(Director) |
A | Common Stock | A | 11255 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Hughes Douglas J.
(Director) |
A | Common Stock | A | 11255 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | MIGAUSKY GEORGE V
(Director) |
A | Common Stock | A | 11255 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Pande Atul
(Director) |
A | Common Stock | A | 11255 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Torti Frank
(Director) |
A | Common Stock | A | 120400 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Stout Jay S
(Chief Technology Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Macias William L.
(Chief Medical Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Geffner Michael
(Chief Medical Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Butchko Julia G.
(Chief Development Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
A | Common Stock | A | 54978 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
A | Common Stock | A | 160534 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Immunovant, Inc. | Macias William L.
(Chief Medical Officer) |
S | Common Stock | D | 2221 | $36.15 - $36.15 | $80,289 |
| 2024-01-11 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
S | Common Stock | D | 3515 | $41.64 - $42.43 | $147,022 |
| 2024-01-05 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 3824 | $38.59 - $38.59 | $147,568 |
| 2023-11-22 | Immunovant, Inc. | Salzmann Peter
(Chief Executive Officer) |
S | Common Stock | D | 16217 | $32.75 - $33.52 | $531,580 |
| 2023-11-22 | Immunovant, Inc. | Barnett Eva Renee
(Chief Financial Officer) |
S | Common Stock | D | 4055 | $32.75 - $33.52 | $132,919 |
| 2023-11-22 | Immunovant, Inc. | Butchko Julia G.
(Chief Development Officer) |
S | Common Stock | D | 3265 | $32.75 - $33.52 | $107,023 |
| 2023-11-22 | Immunovant, Inc. | Macias William L.
(Chief Medical Officer) |
S | Common Stock | D | 3265 | $32.75 - $33.52 | $107,023 |
| 2023-11-22 | Immunovant, Inc. | Levine Mark S.
(Chief Legal Officer) |
S | Common Stock | D | 3252 | $32.75 - $33.52 | $106,598 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |